GSK, Teva To Take Lamictal Pay-For-Delay Case To High Court
By Melissa Lipman ( October 6, 2015, 5:33 PM EDT) -- GlaxoSmithKline and Teva told a New Jersey federal court on Monday that they plan to ask the U.S. Supreme Court to review whether a pay-for-delay class action against them should be nixed because their settlement over Lamictal patents didn't involve a cash payment....
Law360 is on it, so you are, too.
A Law360 subscription puts you at the center of fast-moving legal issues, trends and developments so you can act with speed and confidence. Over 200 articles are published daily across more than 60 topics, industries, practice areas and jurisdictions.
A Law360 subscription includes features such as
- Daily newsletters
- Expert analysis
- Mobile app
- Advanced search
- Judge information
- Real-time alerts
- 450K+ searchable archived articles
And more!
Experience Law360 today with a free 7-day trial.